A disciplined, highly targeted approach to discovering new cancer medicines
Rigorous, definitive clinical trials based on deep biology and chemistry expertise
Committed to bringing differentiated new cancer medicines to patients
ARIAD's first internally discovered and developed medicine
ARIAD Announces Adoption of Final Opinion for Iclusig by Committee for Medicinal Products for Human Use in Europe
ARIAD to Webcast Conference Call on Third Quarter 2014 Financial Results
A shared commitment to patients and each other. This is ARIAD.
click here for PDF